alpha-cyano-4-hydroxycinnamate has been researched along with Fibrocystic Breast Disease in 1 studies
alpha-cyano-4-hydroxycinnamate: specific inhibitor of pyruvate transport in rat liver mitochondria & human erythrocytes; structure
Fibrocystic Breast Disease: A common and benign breast disease characterized by varying degree of fibrocystic changes in the breast tissue. There are three major patterns of morphological changes, including FIBROSIS, formation of CYSTS, and proliferation of glandular tissue (adenosis). The fibrocystic breast has a dense irregular, lumpy, bumpy consistency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wahl, ML | 1 |
| Pooler, PM | 1 |
| Briand, P | 1 |
| Leeper, DB | 1 |
| Owen, CS | 1 |
1 other study available for alpha-cyano-4-hydroxycinnamate and Fibrocystic Breast Disease
| Article | Year |
|---|---|
Intracellular pH regulation in a nonmalignant and a derived malignant human breast cell line.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Breast; Breast Neoplasms; Cell Line, Transformed; | 2000 |